| scholarly article | Q13442814 |
| P356 | DOI | 10.1089/152308602753666280 |
| P698 | PubMed publication ID | 12006174 |
| P50 | author | Roberta Foresti | Q56766946 |
| Roberto Motterlini | Q56766953 | ||
| Aneta Kasza | Q66812015 | ||
| Józef Dulak | Q85863579 | ||
| Otmar Pachinger | Q114330813 | ||
| Alicja Józkowicz | Q42305518 | ||
| P2093 | author name string | Franz Weidinger | |
| Matthias Frick | |||
| Colin J Green | |||
| Ihor Huk | |||
| P2860 | cites work | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | Q22009936 |
| P433 | issue | 2 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 229-240 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Antioxidants & Redox Signaling | Q4775078 |
| P1476 | title | Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells | |
| P478 | volume | 4 |
| Q36681794 | (S)-1-α-naphthylmethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712), promotes wound closure by producing VEGF through HO-1 induction in human dermal fibroblasts and mouse skin |
| Q54588260 | Angiogenin and hemoxygenase in pregnancy: influence of hypertension. |
| Q34429244 | Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy |
| Q42266376 | Arteriolar genesis and angiogenesis induced by endothelial nitric oxide synthase overexpression results in a mature vasculature. |
| Q30993830 | Ascorbic acid partly antagonizes resveratrol mediated heme oxygenase-1 but not paraoxonase-1 induction in cultured hepatocytes - role of the redox-regulated transcription factor Nrf2. |
| Q41833012 | Atorvastatin affects several angiogenic mediators in human endothelial cells |
| Q34696107 | Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells |
| Q24296841 | Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration |
| Q28268811 | Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance |
| Q40425297 | Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages |
| Q36071425 | DEP induction of ROS in capillary-like endothelial tubes leads to VEGF-A expression |
| Q34243596 | Disrupted postnatal lung development in heme oxygenase-1 deficient mice. |
| Q43251758 | Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes |
| Q42872663 | Exploring the potential of low doses carbon monoxide as therapy in pregnancy complications |
| Q28574778 | Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia |
| Q40605721 | Gene expression profiling of the hypoxia signaling pathway in hypoxia-inducible factor 1alpha null mouse embryonic fibroblasts |
| Q24632135 | Gene therapy for ischemic heart disease |
| Q24314945 | Gene transfer of CuZn superoxide dismutase enhances the synthesis of vascular endothelial growth factor |
| Q45874938 | HIF-regulated HO-1 gene transfer improves the post-ischemic limb recovery and diminishes TLR-triggered immune responses - Effects modified by concomitant VEGF overexpression |
| Q39285687 | HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation |
| Q37847616 | Haem oxygenase-1 and cardiovascular disease: mechanisms and therapeutic potential |
| Q37944861 | Haem oxygenase-1: non-canonical roles in physiology and pathology |
| Q89820050 | Heme Oxygenase Dependent Bilirubin Generation in Vascular Cells: A Role in Preventing Endothelial Dysfunction in Local Tissue Microenvironment? |
| Q38823562 | Heme Oxygenases in Cardiovascular Health and Disease |
| Q37312044 | Heme oxygenase in pregnancy and preeclampsia |
| Q34334879 | Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities |
| Q52431393 | Heme oxygenase inhibition in cancers: possible tools and targets. |
| Q37065405 | Heme oxygenase inhibition increases blood pressure in pregnant rats |
| Q33460409 | Heme oxygenase-1 accelerates cutaneous wound healing in mice |
| Q40434186 | Heme oxygenase-1 accelerates protumoral effects of nitric oxide in cancer cells |
| Q37057022 | Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis |
| Q36174178 | Heme oxygenase-1 in tumors: is it a false friend? |
| Q34995661 | Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo |
| Q35567381 | Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. |
| Q34937179 | Heme oxygenase-1 is critically involved in placentation, spiral artery remodeling, and blood pressure regulation during murine pregnancy |
| Q24322029 | Heme oxygenase-1 modulates the expression of the anti-angiogenic chemokine CXCL-10 in renal tubular epithelial cells |
| Q50632490 | Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. |
| Q42048022 | Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. |
| Q41816300 | Heme oxygenase-1-dependent and -independent regulation of angiogenic genes expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells. |
| Q34537034 | Heme oxygenase-1/carbon monoxide induces vascular endothelial growth factor expression via p38 kinase-dependent activation of Sp1 |
| Q35110952 | Heme oxygenase‐1 in growth control and its clinical application to vascular disease |
| Q34579466 | Hypoxia-responsive microRNA-101 promotes angiogenesis via heme oxygenase-1/vascular endothelial growth factor axis by targeting cullin 3 |
| Q37076510 | Identification of cyclins A1, E1 and vimentin as downstream targets of heme oxygenase-1 in vascular endothelial growth factor-mediated angiogenesis |
| Q45018807 | Immunohistochemical analysis of heme oxygenase-1 in preneoplastic and neoplastic lesions during chemical hepatocarcinogenesis |
| Q83288968 | Increased levels of plasma haemoxygenase-1 in prostate cancer |
| Q35543410 | Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats |
| Q42805129 | Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor |
| Q38284366 | Involvement of the heme oxygenase system in the development of preeclampsia and as a possible therapeutic target |
| Q34109492 | Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms? |
| Q91433898 | Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase-1 |
| Q33572306 | Molecular regulation of tumor angiogenesis and perfusion via redox signaling |
| Q36385632 | New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genes |
| Q33463931 | Non-thermal plasma activates human keratinocytes by stimulation of antioxidant and phase II pathways |
| Q37653925 | Nrf2 regulates angiogenesis: effect on endothelial cells, bone marrow-derived proangiogenic cells and hind limb ischemia |
| Q35569881 | Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice |
| Q39927394 | Possible relation of hemin-induced HO-1 expression to the upregulation of VEGF and BDNF mRNA levels in rat C6 glioma cells |
| Q45150273 | Potential role of heme oxygenase-1 in the progression of rat adjuvant arthritis |
| Q46374490 | Pro-oxidant role of heme oxygenase in mediating glucose-induced endothelial cell damage. |
| Q39256530 | Redox regulation of gasotransmission in the vascular system: A focus on angiogenesis |
| Q36183868 | Regulation of ROS production and vascular function by carbon monoxide |
| Q26751266 | Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism |
| Q55332985 | Simvastatin Treatment Upregulates HO-1 in Patients with Abdominal Aortic Aneurysm but Independently of Nrf2. |
| Q42755299 | Spironolactone and enalapril differentially up-regulate the expression of VEGF and heme oxygenase-1 in the neonatal rat kidney |
| Q42452556 | Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells |
| Q36591335 | Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds |
| Q64284712 | Targeting angiogenesis in Duchenne muscular dystrophy |
| Q37425533 | Temporal changes of angiopoietins and Tie2 expression in rat lungs after monocrotaline-induced pulmonary hypertension. |
| Q34295822 | The heme oxygenases: important regulators of pregnancy and preeclampsia |
| Q37044976 | The roles of hyperglycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endothelial cell dysfunction in diabetes |
| Q48467525 | Time-dependent changes in cerebrospinal fluid metal ions following aneurysm subarachnoid hemorrhage and their association with cerebral vasospasm. |
Search more.